Molecular Imaging & Therapeutics

What We Offer

We provide advanced nuclear medicine, PET/CT, and PET/MR imaging for accurate diagnosis, and to guide personalized treatment. In addition to imaging services, we also provide radiopharmaceutical therapies for treatment of cancers and hyperthyroidism.

We offer leading-edge technology, including advanced scanner infrastructure, and an on-site cyclotron and a dedicated team of radiochemists and radiopharmacists who develop radiopharmaceuticals. This expertise enables us to offer cutting edge imaging and treatment including theranostics for precise targeting and treatment of disease.

Our team collaborates with expert researchers and clinicians in oncology (cancer), cardiology (heart), and neuroscience (brain), to bring the most advanced imaging and treatment options available.

Radiologist standing in front of PET CT scanner

Prostate Cancer Imaging

“Three years after receiving US Food and Drug Administration (FDA) approval of the technique, we continue to work to advance our collective education in PSMA, so that we’re better equipped to accelerate the development of these new therapies and make significant strides toward improving the lives of prostate cancer patients.”

Thomas Hope, MD

Why Choose UCSF for Molecular Imaging & Therapeutics?

Expertise in adult and pediatric molecular imaging including comprehensive cancer and advanced nuclear cardiology imaging studies
Advanced imaging modalities including PET/CT and PET/MRI, using theranostic agents which allow both diagnosis and therapy
UCSF was among the first to offer 68Ga-PSMA-11, a ground-breaking, FDA-approved detection and treatment agent for prostate cancer, developed in collaboration with UCLA
On-site cyclotron to produce radionuclides, with a team of expert radiochemists and radio pharmacists